Friday, February 20, 2026

Global Biomass Power Market Snapshot 2035: Trends, Growth & Regional Insights

 


The global biomass power generation market was valued at US$ 94.8 Bn in 2024 and is projected to reach US$ 136.2 Bn by 2035, expanding at a steady CAGR of 3.4% from 2025 to 2035. Growth is being shaped by the dual priorities of strengthening energy security and accelerating decarbonization across global economies.

Analysts’ Viewpoint

Biomass power remains a critical component of the renewable energy mix because of its ability to provide dispatchable, baseload electricity—an advantage over intermittent sources such as solar and wind. Industrial users account for nearly 48% of global biomass power demand, leveraging it for consistent energy supply and cost stability.

Europe leads the global market with nearly 40% share, supported by progressive climate regulations and established district heating networks. Meanwhile, Asia-Pacific is expected to record the fastest growth due to abundant feedstock availability and rising energy demand. Leading players such as Drax Group plc and Ørsted A/S continue to advance biomass integration into large-scale grid systems and combined heat and power (CHP) facilities.

In the long term, supportive government incentives and monetization of carbon credits are expected to reinforce biomass as a commercially viable pillar of the clean energy transition.

Market Overview

Biomass power generation utilizes organic materials such as agricultural residues, forestry by-products, wood pellets, municipal solid waste, and industrial wastewater to produce electricity and heat. It contributes to waste reduction and supports circular economy initiatives by converting organic waste into usable energy.

Governments worldwide are encouraging biomass adoption through renewable portfolio standards, tax incentives, subsidies, feed-in tariffs, and renewable purchase obligations. Unlike wind and solar, biomass plants can operate continuously, making them reliable baseload energy sources for utilities and industrial facilities.

Emerging economies in Asia-Pacific and Latin America are rapidly expanding biomass capacity due to ample agricultural residues and increasing focus on domestic energy production.

 

Get Sample PDF Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4495

 

Key Market Drivers

Rising Global Focus on Renewable Energy and Decarbonization

Global commitments to achieve net-zero emissions by 2050 are significantly accelerating renewable energy deployment. Biomass complements intermittent renewables by providing dispatchable power.

The European Union’s Renewable Energy Directive II (RED II) mandates at least 32% renewable energy consumption by 2030, with strong emphasis on plant-based biomass. India has set a national target of 10 GW biomass capacity by 2030, while China generates over 140 TWh of biomass electricity annually.

Supportive policies such as feed-in tariffs and carbon credit programs continue to enhance commercial viability for industrial and utility-scale biomass projects.

Abundant Agricultural and Forestry Residues

An estimated 140 billion metric tons of biomass residues are generated annually worldwide. Much of this remains underutilized.

India produces approximately 500 million tons of crop residues each year, much of which contributes to air pollution when burned. Organized biomass power systems convert such waste into productive energy, reducing environmental impact. China utilizes nearly 60 million tons of agricultural residues annually, supporting over 35 GW of installed biomass capacity. In Europe, forestry waste and wood pellets significantly contribute to renewable heating and electricity.

End-use Insights: Industrial Sector Leads

The industrial sector accounts for nearly 48% of global biomass power installations, driven by high and continuous energy requirements.

In India, the sugar industry generates over 8,000 MW annually from bagasse-based biomass plants, serving both captive consumption and grid supply. Europe’s pulp and paper sector consumes around 55 million tons of biomass annually. Japan has commissioned more than 70 biomass projects since 2020, particularly in industrial parks.

Biomass enables industries to enhance energy security, reduce carbon footprints, and achieve cost efficiencies through localized residue utilization.

Regional Insights

Europe remains the leading region, holding nearly 40% of global biomass capacity. Countries such as Sweden and Finland derive over 20% of district heating from biomass, demonstrating large-scale integration into urban energy systems.

North America leverages abundant forestry and agricultural feedstock. Canada alone generates more than 2,000 MW of biomass electricity, particularly in British Columbia.

Asia-Pacific is the fastest-growing region. Japan added over 500 MW of biomass capacity in 2023 under its feed-in tariff scheme, while Thailand derives approximately 8% of its energy from biomass, primarily using palm oil and sugar residues.

Competitive Landscape

Major players in the biomass power generation market include Drax Group plc, Ørsted A/S, ACCIONA, RWE, MGT Teesside Ltd, Babcock & Wilcox, Vattenfall AB, Ameresco, Inc., Engie SA, E.ON Global, Xcel Energy Inc, Energetický a průmyslový holding (EPH), RENOVA, Inc., and EDF.

Recent developments highlight the sector’s transition toward carbon-negative solutions. Ørsted plans to initiate carbon capture at its biomass CHP stations in 2025, targeting 400,000 tonnes of CO₂ capture annually. Drax Group has submitted plans to convert biomass units into Bioenergy with Carbon Capture and Storage (BECCS) facilities capable of removing up to 8 million tonnes of CO₂ annually.

Conclusion

While growth remains moderate at 3.4% CAGR, biomass power generation continues to play a crucial role in the global clean energy landscape. With strong policy backing, industrial demand, and carbon capture advancements, biomass is positioned as a dependable and scalable renewable energy solution through 2035.

Stick Electrodes Dominate as Infrastructure Development Powers India Welding Consumables Market

 


The India welding consumables market is poised for steady expansion over the next decade, supported by rapid infrastructure development, automotive growth, and strengthening domestic manufacturing capabilities. Valued at US$ 1.2 Bn in 2024, the market is projected to grow at a CAGR of 6.4% from 2025 to 2035, reaching approximately US$ 2.4 Bn by the end of the forecast period. The industry’s upward trajectory reflects India’s broader economic transformation and increasing focus on industrial self-reliance.

Welding consumables play a critical role in joining metal components to ensure structural integrity, strength, and durability across industries. These materials influence deposition rates, arc stability, corrosion resistance, and overall welding performance. With advancements in welding technologies, manufacturers are increasingly developing high-efficiency consumables that improve precision while reducing environmental impact.

One of the primary growth drivers for the India welding consumables market is rapid infrastructure development and urbanization. Government-led initiatives such as Bharatmala Pariyojana, Smart Cities Mission, and Pradhan Mantri Awas Yojana have significantly boosted demand for structural welding materials. Massive investments in highways, metro rail expansions, bridges, ports, and housing projects require large volumes of electrodes, filler wires, and fluxes. Infrastructure spending continues to rise year after year, creating sustained demand for welding solutions across construction and public works sectors.

Get Sample PDF Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4324

The expanding automotive and manufacturing sectors further accelerate market growth. India ranks among the world’s largest automobile producers, with strong domestic sales and export momentum. Welding consumables such as MIG and TIG wires are essential in manufacturing vehicle frames, chassis, and other critical components. Additionally, the Production Linked Incentive (PLI) scheme and the “Make in India” initiative are promoting domestic production of electronics, defense equipment, and heavy machinery—industries that heavily rely on advanced welding technologies. As automation and robotic welding gain traction in manufacturing plants, demand for high-performance flux-cored wires and specialized consumables is expected to increase significantly.

By type, stick electrodes dominate the market, accounting for over 46% of total share. Their widespread adoption is attributed to affordability, ease of use, and strong performance in outdoor and manual welding applications. Stick electrodes are extensively used in construction, railway projects, and repair works, particularly in infrastructure-heavy environments where cost efficiency and reliability are critical.

Regionally, Maharashtra leads the India welding consumables market, contributing approximately 18% of the national share. The state’s strong industrial ecosystem—including automotive, engineering, shipbuilding, and construction industries—drives substantial demand. Industrial clusters around Pune, Mumbai, and Nashik serve as key consumption hubs. Large infrastructure projects such as metro rail expansions and coastal developments further reinforce Maharashtra’s leadership position.

The competitive landscape is characterized by established players with extensive product portfolios and strong distribution networks. Companies such as ESAB India Limited and Ador Welding Limited hold significant market positions, leveraging technological innovation, R&D capabilities, and broad industry reach. Recent developments, including energy-efficient digital welding machines and compliance with international standards, highlight the industry’s focus on sustainability and quality enhancement.

Overall, the India welding consumables market is set to witness sustained growth, driven by infrastructure expansion, industrial modernization, and supportive government policies. As India continues its journey toward becoming a global manufacturing hub, welding consumables will remain a foundational component of its industrial progress.

Global Exosome Technologies Outlook 2035: Diagnostics, Drug Delivery & Vaccine Development

 


The global exosome technologies market was valued at US$ 204.7 Mn in 2024 and is projected to grow at a remarkable CAGR of 18.2% from 2025 to 2035, crossing US$ 1.3 Bn by the end of 2035.

This rapid expansion reflects the growing clinical and research adoption of exosome-based diagnostics and therapeutics, particularly in oncology, cardiology, and neurodegenerative diseases.

 

Market Introduction

Exosomes are small extracellular vesicles released by cells that play a crucial role in intercellular communication. They carry:

  • Proteins
  • Lipids
  • DNA and RNA fragments

Their ability to reflect physiological and pathological conditions makes them highly valuable for diagnostic and therapeutic applications.

Exosome technologies encompass:

  • Isolation kits
  • Characterization kits
  • Detection platforms
  • Analytical instruments
  • Software and services

Advanced extraction methods such as ultracentrifugation, size-exclusion chromatography, and microfluidics enable precise exosome isolation from biological fluids.

 

Get Sample PDF Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=65840

 

Key Market Drivers

1. Rising Prevalence of Chronic Diseases

Chronic diseases such as cancer, cardiovascular disorders, diabetes, and neurological conditions account for nearly 74% of global deaths. Early diagnosis and targeted therapies are critical.

Exosomes enable:

  • Non-invasive disease detection
  • Real-time disease monitoring
  • Personalized therapeutic targeting
  • Delivery of siRNA, microRNA, and other drug molecules

This positions exosome technologies at the forefront of next-generation disease management.

 

2. Increasing Adoption of Exosome-Based Diagnostics

Liquid biopsy platforms based on exosomal biomarkers are gaining traction due to their non-invasive nature and high sensitivity.

Clinical validation is expanding rapidly:

  • Growing number of global clinical trials evaluating exosome diagnostics
  • Regulatory approvals boosting institutional confidence
  • Increased demand for point-of-care (POC) solutions

The success of exosome-based prostate and lung cancer diagnostic tests highlights expanding clinical acceptance.

 

Product Type Insights

Kits & Reagents – Leading Segment

The kits and reagents segment dominates the market due to:

  • Standardization and reproducibility
  • Ease of use across laboratories
  • High sensitivity and scalability
  • Strong adoption in both research and clinical settings

As diagnostic and therapeutic applications expand, demand for reliable, ready-to-use kits continues to rise.

 

Therapeutic & Diagnostic Applications

Exosome technologies are applied across:

Diagnostics

  • Liquid biopsies
  • Biomarker discovery
  • Disease monitoring

Therapeutics

  • Drug delivery systems
  • Tissue regeneration
  • Vaccine development
  • Gene therapy

Synthetic exosome mimetics are also emerging as cost-effective alternatives for therapeutic development.

 

Regional Outlook

North America – Market Leader

North America leads the global exosome technologies market due to:

  • Advanced biomedical infrastructure
  • Strong R&D funding
  • Early clinical adoption of innovative diagnostics
  • Regulatory support from agencies like the FDA

The region’s strong academic–biotech collaboration ecosystem supports rapid commercialization.

 

Europe & Asia Pacific – Expanding Innovation Hubs

Europe continues to strengthen clinical validation and therapeutic research programs, while Asia Pacific is witnessing increasing biotech investments and research expansion, particularly in China, Japan, and South Korea.

 

Competitive Landscape

Leading players in the exosome technologies market include:

ExoCan Healthcare Technologies Pvt Ltd, Capricor Therapeutics, Inc., Exocobio, Creative Biolabs, VivaZome Therapeutics Pty Ltd, EXO Biologics, Exosome Diagnostics GmbH, Coya Therapeutics, Inc., RION, Thermo Fisher Scientific, System Biosciences, LLC, AEGLE Therapeutics, Fujifilm Holding Corporation, Bio-Techne Corporation, NOVIQ, and NITTA GELATIN INDIA LIMITED.

Strategic Focus Areas

  • Clinical trial validation
  • Regulatory approvals (e.g., FDA clearances)
  • Strategic collaborations and partnerships
  • Mergers and acquisitions
  • Development of scalable GMP-grade production platforms

 

Key Developments

  • August 2025: Capricor Therapeutics initiated Phase 1 clinical dosing for its StealthX exosome-based vaccine platform under NIH funding.
  • April 2024: EXO Biologics secured up to EUR 16 Mn in Series A funding to expand manufacturing and clinical development under its EXOPulse production platform.

These milestones highlight increasing institutional confidence in exosome-based platforms.

 

Conclusion

The exosome technologies market is poised for high-growth transformation, fueled by innovation in personalized medicine and minimally invasive diagnostics. As standardization improves and regulatory clarity strengthens, exosomes are expected to transition from research tools to mainstream clinical solutions.

With strong momentum in liquid biopsies, chronic disease management, and advanced therapeutics, the industry is set to become a cornerstone of next-generation biotechnology through 2035.

Popular Posts

Categories

About Us

About Us
Welcome to 24Newsletter, your go-to destination for the latest insights, trends, and updates across industries. Our mission is to deliver concise, accurate, and engaging content to keep you informed and ahead of the curve. Whether it’s technology, business, health, or lifestyle, we bring you stories that matter, 24/7.